ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $42,000 | -98.7% | 42,000 | -98.7% | 0.00% | -100.0% |
Q2 2021 | $3,207,000 | -88.8% | 3,193,000 | -88.7% | 0.03% | -85.6% |
Q1 2021 | $28,739,000 | -5.5% | 28,304,000 | +0.8% | 0.21% | -0.5% |
Q4 2020 | $30,397,000 | -10.7% | 28,073,000 | -14.6% | 0.21% | -9.1% |
Q3 2020 | $34,043,000 | -6.4% | 32,870,000 | -0.1% | 0.23% | -20.3% |
Q2 2020 | $36,358,000 | +8.9% | 32,911,000 | +0.0% | 0.29% | -6.1% |
Q1 2020 | $33,383,000 | -11.2% | 32,910,000 | +0.3% | 0.31% | +19.3% |
Q4 2019 | $37,597,000 | -42.2% | 32,796,000 | -42.3% | 0.26% | -34.6% |
Q3 2019 | $65,003,000 | +61.7% | 56,879,000 | +67.7% | 0.40% | +44.5% |
Q2 2019 | $40,192,000 | -7.8% | 33,922,000 | +5.3% | 0.27% | -13.3% |
Q1 2019 | $43,605,000 | +25.7% | 32,203,000 | -0.3% | 0.32% | +12.5% |
Q4 2018 | $34,693,000 | +2.3% | 32,284,000 | +0.1% | 0.28% | +8.5% |
Q3 2018 | $33,926,000 | +16.3% | 32,241,000 | +8.9% | 0.26% | +28.2% |
Q2 2018 | $29,163,000 | +20.9% | 29,615,000 | +21.6% | 0.20% | +34.7% |
Q1 2018 | $24,124,000 | -6.3% | 24,364,000 | +0.1% | 0.15% | -84.1% |
Q4 2017 | $25,755,000 | +0.7% | 24,347,000 | +0.8% | 0.94% | -1.1% |
Q3 2017 | $25,567,000 | +4.8% | 24,155,000 | +5.2% | 0.95% | -7.8% |
Q2 2017 | $24,396,000 | +35.7% | 22,954,000 | +23.2% | 1.03% | +26.2% |
Q1 2017 | $17,982,000 | +73.9% | 18,629,000 | +82.1% | 0.82% | +65.9% |
Q4 2016 | $10,340,000 | +8.2% | 10,231,000 | -0.1% | 0.49% | +14.4% |
Q3 2016 | $9,558,000 | +31.5% | 10,243,000 | 0.0% | 0.43% | +19.1% |
Q2 2016 | $7,266,000 | -22.3% | 10,243,000 | 0.0% | 0.36% | -28.9% |
Q1 2016 | $9,347,000 | -19.1% | 10,243,000 | 0.0% | 0.51% | -18.8% |
Q4 2015 | $11,549,000 | – | 10,243,000 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|